PRESS RELEASE published on 06/03/2025 at 12:10, 1 year 1 month ago Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRIEF published on 04/14/2025 at 13:05, 1 year 2 months ago Lobe Sciences lance un placement privé pour le développement de médicaments Placement Privé Essais Cliniques Sciences Du Lobe Cynaptec Pharmaceuticals Psilocine Conjuguée
BRIEF published on 04/14/2025 at 13:05, 1 year 2 months ago Lobe Sciences Initiates Private Placement for Drug Development Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
PRESS RELEASE published on 04/14/2025 at 13:00, 1 year 2 months ago Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
BRIEF published on 04/05/2025 at 05:55, 1 year 3 months ago Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRIEF published on 04/05/2025 at 05:55, 1 year 3 months ago Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine
PRESS RELEASE published on 04/05/2025 at 05:50, 1 year 3 months ago Lobe Sciences Provides Corporate Update Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
Published on 07/13/2026 at 15:27, 2 hours 23 minutes ago As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
Published on 07/13/2026 at 15:10, 2 hours 40 minutes ago iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer
Published on 07/13/2026 at 14:30, 3 hours 20 minutes ago Unusual Machines Promotes Tyler Crane to Vice President of Product
Published on 07/13/2026 at 14:00, 3 hours 50 minutes ago CHAR Tech se réjouit du plan énergétique de 87 milliard $ du Québec misant sur la biomasse pour la transition vers les énergies renouvelables
Published on 07/13/2026 at 17:46, 3 minutes ago EQS-Adhoc: Shelly Group reports preliminary group revenue for the first half of 2026
Published on 07/13/2026 at 17:00, 49 minutes ago EQS-Adhoc: Leifheit Aktiengesellschaft: Leifheit approves the execution of the FOCUS performance program to sustainably improve profitability and adjusts its forecast for FY 2026
Published on 07/13/2026 at 16:45, 1 hour 5 minutes ago Alta Group announcement on Voluntary Takeover Offers for Addiko Bank AG
Published on 07/13/2026 at 16:05, 1 hour 44 minutes ago 2026 Yinghua Fellowship Summer Camp Concludes Successfully
Published on 07/13/2026 at 16:00, 1 hour 50 minutes ago SMAG Mobile Antenna Masts AG successfully starts trading on the Scale Segment of the Frankfurt Stock Exchange
Published on 07/13/2026 at 17:40, 10 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 6 au 10 juillet 2026 dans le cadre du programme de rachat d’actions.
Published on 07/13/2026 at 09:20, 8 hours 29 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 mai 2026 bis
Published on 07/13/2026 at 07:30, 10 hours 20 minutes ago Déclaration hebdomadaire d'opérations effectuées du 6 au 10 juillet 2026